
|Podcasts|October 7, 2021
The Cutaneous Connection: Episode 32-Understanding Type 2 Inflammation
In this episode, Marc Serota, MD, discusses his research regarding type 2 inflammation, the future of treating it as 1 condition or 2, and more!
Advertisement
In this episode of The Cutaneous Connection, Marc Serota, MD, discusses his research regarding type 2 inflammation, the future of treating it as 1 condition or 2, and why physicians should educate their patients about this type of inflammation.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Kyowa Kirin Takes Full Control of Rocatinlimab Program
2
Dermatology Times January 2026 Recap
3
Phase 2 TYK2 Inhibition Shows Promise in AD
4
Icotrokinra Shows Superior Efficacy Over Advanced Oral Therapies in New Psoriasis Meta-Analysis
5









